ArticlePDF Available

EFFICACY OF PANCHAKARMA IN SANDHIVATA W.S.R. TO KNEE ARTHRITIS

Authors:

Abstract

Inflammation of knee joint is called knee arthritis. Among various forms of knee arthritis common is degenerative type of knee osteoarthritis It is the major cause of loco motor disability in old age people particularly among women. Analgesics and Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) are the current available pharmaceutical management of knee osteoarthritis which are associated with adverse side effects. Thus, there is need of research in traditional system of medicines for cost effective and long-term management of knee OA. Degenerative Knee osteo arthritis is almost similar to the Sandhivata describes in Ayuveda with respect to aetiology, pathology and clinical features. With the use of medicines Ayurveda also employs the prospective of Panchakarma in the various therapeutic measures, which is a kind of Shodhan Chikitsa. Panchakarma provides various therapeutic benefits as detoxification, improved circulation, spasm and pain relief. Hence objective of this review article is to describe the efficacy of Panchakarma in knee-arthritis with taking consideration of disease mentioned in Ayurvedic classics as Sandhivata
Review Article ISSN: 2320-5091 Impact Factor: 6.719
EFFICACY OF PANCHAKARMA IN SANDHIVATA W.S.R. TO KNEE ARTHRITIS
Tanuja Mehta1, Vipin Kumar2, Sheetal Verma3, Uttam Kumar Sharma4
1PG Scholar 1st Year, Department of Panchakarma,
2Assistant Professor, Samhita, Sanskrit Evum Siddhanta Dept.,
3Associate Professor, Samhita, Sanskrit Evum Siddhanta Dept.,
4Professor and Head, Department of Panchakarma,
Uttarakhand Ayurved University, Gurukul Campus, Haridwar, Uttarakhand, India
Corresponding Author: tanuja16oct@gmail.com
https://doi.org/10.46607/iamj.3409012021
(Published online: January 2021)
Open Access
© International Ayurvedic Medical Journal, India 2021
Article Received: 26/12/2020 - Peer Reviewed: 28/12/2020 - Accepted for Publication: 31/12/2020
ABSTRACT
Inflammation of knee joint is called knee arthritis. Among various forms of knee arthritis common is degenerative
type of knee osteoarthritis It is the major cause of loco motor disability in old age people particularly among wom-
en. Analgesics and Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) are the current available pharmaceutical
management of knee osteoarthritis which are associated with adverse side effects. Thus, there is need of research in
traditional system of medicines for cost effective and long-term management of knee OA. Degenerative Knee os-
teo arthritis is almost similar to the Sandhivata describes in Ayuveda with respect to aetiology, pathology and clini-
cal features. With the use of medicines Ayurveda also employs the prospective of Panchakarma in the various
therapeutic measures, which is a kind of Shodhan Chikitsa. Panchakarma provides various therapeutic benefits as
detoxification, improved circulation, spasm and pain relief. Hence objective of this review article is to describe the
efficacy of Panchakarma in knee-arthritis with taking consideration of disease mentioned in Ayurvedic classics as
Sandhivata
Keywords: Ayurved, Panchakarma, Sandhivata.
INTERNATIONAL
AYURVEDIC
MEDICAL JOURNAL
Tanuja Mehta et al: Efficacy Of Panchakarma In Sandhivata W.S.R. To Knee Arthritis
doi:10.46607/iamj.3409012021 | IAMJ January 2021 | www.iamj.in
213
INTRODUCTION
Arthritis and Knee Joint, Arthritis is the blanket term
use to refer more than 100 rheumatic diseases and
conditions that affects the joints, tissue surrounding
the joints and the other connective tissue 1. Knee Ar-
thritis includes the primary symptoms of inflammation
like Pain, swelling, and stiffness. Knee is the largest
synovial joint in humans, which is composed of osse-
ous structures (distal femur, proximal tibia, and patel-
la), cartilage (meniscus and hyaline cartilage), liga-
ments and a synovial membrane. The latter is in
charge of the production of the synovial fluid, which
provides lubrication and nutrients to the avascular car-
tilage 2. Unfortunately, given the high use and stress
on knee joint, it becomes a frequent site for painful
conditions like OA 3,4 which mainly afflicts the knee
joint in the transition period between middle age and
old age.5,6,7 particularly in women who are progressing
towards menopause or those who have already set in 8.
Knee Osteoarthritis-
Different from inflammatory arthritis, inflammation in
OA is chronic and low-grade inflammation, involving
mainly innate immune mechanisms. Synovitis (infil-
tration of inflammatory cells into the synovium) is a
common finding of OA and it can be present in early
stages of the disease but is more prevalent towards the
more advanced stages and can be related with severi-
ty9. Previously knee osteoarthritis was interpreted as
wear and tear of the articular cartilage disease because
of ageing and not related to inflammation. Although
the disease pathophysiology is still poorly understood
and is under investigation, now it is accepted that knee
osteoarthritis is multi factorial in origin where both
inflammatory and biomechanical whole organ disease
processes plays an important role. Knee osteoarthritis
influenced by combination of factors including age,
obesity, joint integrity, genetic predisposition, lower
limb alignment, trauma and inflammation by metabol-
ic syndrome. 10-17 knee osteoarthritis implicit articular
cartilage damage, bony osteophytes formation, sclero-
sis of the subchondral bone and in advanced cases
subchondral cyst formation pathologically regardless
of the underlying mechanism.
Classification of Knee Osteoarthritis-
According to its aetiology OA is classified into two
groups: primary (idiopathic or non-traumatic) and
secondary (usually due to trauma or mechanical misa-
lignment).
One of the clinical classification criteria most fre-
quently used is the one developed by the American
College of Rheumatology. 18,19
Clinical Knee pain for most days of the prior month,
in addition to at least 3 of the following:
Crepitus on active joint motion
Morning stiffness less than 30 minutes’ duration
Age older than 50 years
Bony enlargement of the knee on examination
Bony tenderness of the knee on examination
No palpable warmth.
Clinical plus radiographic: Knee pain for most days
of the prior month, plus radiographic evidence of os-
teophytes on joint margins in addition to 1 of the fol-
lowing:
1. Crepitus on active motion
2. Morning stiffness less than 30 minutes’ duration
3. Age older than 50 years.
Clinical plus laboratory: Knee pain for most days of
the prior month, in addition to at least 5 of the follow-
ing:
1. Crepitus on active joint motion
2. Morning stiffness less than 30 minutes’ duration
3. Age older than 50 years
4. Bony tenderness to palpation
5. Bony enlargement
6. No palpable warmth
7. Erythrocyte sedimentation rate below 40 mm/h
8. Rheumatoid factor less than 1:40
9. Synovial fluid consistent with OA (white blood cell
count < 2000/μL).
Sandhivata-
Acharya Charaka was the first person who described
the disease separately named Sandhigata Anila” but
has not included under 80 types. According to Ayur-
veda Pphysiological functions of the body is governed
by three Doshas that is, Vata, Pitta, and Kapha. Vitia-
tion of these Doshas leads in disease manifestation.
Tanuja Mehta et al: Efficacy Of Panchakarma In Sandhivata W.S.R. To Knee Arthritis
doi:10.46607/iamj.3409012021 | IAMJ January 2021 | www.iamj.in
214
As the age progress degeneration of the body parts
occurs due to the influence of vata dosha. Sandhivata
is the result of such degeneration 20. Also, Vata get
aggravated by various reasons other than ageing like
improper diet, injury, exposure to cold, suppression of
natural urges etc. vitiated Vata shelter in the joints.
Due its Rooksha, it dries up the lubricating synovial
fluid inside the joint capsule, degenerates the joints
and can causes the early destruction of cartilage.
Sandhivata is one of the consequences of this process.
Hence Sandhivata is a painful condition of the joint
explained in Ayurvedic text under Vatavyadhi 21, 22, 23
which is characterize by following features-
Shoola (pain)
Vatapurnadruti Sparsha (sound resembling that
made when rub against a balloon or transparent
container filled with air)
Shotha (swelling)
Vedana during Prasaran and Akunchan (painful
movement including extension and flexion)
Atopa (abnormal sounds due to damage of joints
or crepitus)
Sandhihanti (restriction of joint movements)
Treatment
Sandhivata is figures as Kashtsadhya Vyadhi due to
involvement of Vatadoasha, Madhyam Roga Marga
and Dhatu kshaya. Thus, it is important to prevent
early degenerative changes along with treating
Sandhivata. Ayurveda plays an important role in both
of these aspects. A common treatment for Vata Vyadhi
has been described by Acharya Vagabhata i.e. repeat-
ed use of Snehana (Oleation therapy) and Swedana
(Sudation therapy), Basti (Enema) and Mridu
Virechana(Mild Purgative) 24 Acharya Sushruta has
mentioned the treatment for Sandhigata Vata clearly
i.e. Snehana, Upanaha, Agnikarma, Bandhana and
Unmardana25.
Efficacy of Panchakarma -
The therapeutic measures of Ayurveda not only in-
volve use of medicine but also utilizes other ap-
proaches such as; Panchakarma26. Panchakarma is a
very unique therapeutic procedure, because of its pre-
ventive, promotive, prophylactic and rejuvenate prop-
erties as well as providing a radical cure 27. Diseases
which are associated with pain mainly involve local-
ized symptoms and vitiated Vata dosha.28 Pan-
chakarma therapy help to relief localized symptoms in
knee osteoarthritis associated with pain such as in-
flammation, swelling and strain by pacifying the Vata
Dosha.
Mode of Action of Various Panchakarma Thera-
pies in Knee osteoarthritis-29
Snehana-(Oleation Therapy)
It is the first line of treatment explained in the classics
for Sandhivta as Sneha is antagonist to the degenera-
tion process caused by excessive Ruksha Guna (dry
quality) and Khara Guna (rough quality) of vitiated
Vata.
1. Abhyanga (Therapeutic/Preventive Herbal Oil
Massage)- Abhyanga reduces the provoked Vata,
which is responsible for the decay in the Dhatus and
for manifestation of features like pain, stiffness, and
crackers. According to modern studies, massage stim-
ulates blood circulation and assists the lymphatic sys-
tem, improving the elimination of waste throughout
the body. Absorption through the skin can be en-
hanced by suspending the drug in an oily vehicle and
rubbing it on the skin. 30
In cases of osteoarthritis, a study found an 88% im-
provement when combining Abhyanga with steam and
manual traction 31. Patients reported improvement in
joint movement and reduction in joint swelling with
oil applications
2. Janu Basti: Janubasti by lubricating or improving
the local blood circulation in knee joint, it enhances
the mobility of the knee joint and maintains the integ-
rity of the knee joint.
3. Sandhipichu- By nourishing the bone and connec-
tive tissue around the knee joint it prevents the degen-
eration, inflammation in the knee osteoarthritis and
heals pain.
4. Sandhi Lepa- It indicated where Kapha Dosha is
involved along with Vata and helps to reduce stiffness
or effusion in knee osteoarthritis.
Svedana: (fomentation) Svedana is specially indicat-
ed in symptoms like Sankocha (contraction or flex-
ion), Ayama (extension), Shula (pain), Stambha (stiff-
ness), Gaurava (heaviness), and Supti (numbness). 32,
Tanuja Mehta et al: Efficacy Of Panchakarma In Sandhivata W.S.R. To Knee Arthritis
doi:10.46607/iamj.3409012021 | IAMJ January 2021 | www.iamj.in
215
33 These are the usual clinical manifestations of
Sandhigatavata. This panchakarma therapy helps to
enables the free circulation in the joints and relaxes
the muscles, which further reduces the stiffness and
pain, dispenses the symptomatic relief in knee osteo-
arthritis.
Bashpa Swedan- Ekang Bashpa or Nadi Sweda- when
the pain is limited to a part of the body
Pinda Sweda- (bolus formation)-generally done as a
local fomentation, applied on the pain afflicted joints.
1. Churna Pinda Sweda- in it wet bolus prepared
from analgesic and anti-inflammatory herbal
powder used for lubrication in knee osteoarthritis.
2. Patra Panda Sweda (Leaf Bolus Fomentation)-
fresh leaves of Vata alleviating /pain reliving
herbs are used
3. Shashtika Shali Panda Sweda- due to the proper-
ties of rejuvenation, nourishment, strengthen the
bone and connective tissue it is preferred where
there are signs of severe Vata vitiatition and de-
generation of knee joints.
Dhara/Seka (Pizhichill) - herbal oil streams over the
painful knee joints, Upanaha (Poultice Sudation)- is a
type of Svedana indicated in classics34 as one of the
components in the treatment of Sandhigatavata.35
Studies have revealed the fact that lipid medium is
highly suitable for penetration of the drug molecule
through stratum corneum.
Mriduvirechana- Treatment of Sandhigatavata usual-
ly begins with a basic process like Mriduvirechana. It
cleanses the body to restore patency of the Srotasa,
which improve the access of healing material as well
as nourishment to the body components 36.
Basti- Basti is considered to be best Panchakarma
therapy for vitiated Vata and related painful condi-
tions including knee osteoarthritis as it reinforced and
rejuvenates the joint and soft tissues, assist fast heal-
ing and hence enabled the smooth movements at the
knee joints.
Matrabasti- Is a type of Anuvasan Basti 37 Charaka
while assessing the Anuvasana Basti records the di-
gestion of Sneha by the words Sneham Pachati
Pavakah”. Basti, through its action on Vata and Agni,
promotes the formation of Dhatus. According to
Acharya Charak Matrabasti is always applicable to
those emaciated due to overwork, physical exercise,
weight lifting, journey on vehicles, in debilitated per-
son as well afflicted with Vata disorders 38,Matra bas-
ti is a type of Snehabasti, which is unique therapeutic
procedure because of its preventive, promotive, reju-
vinative and curative properties and helps to alleviates
Vata, nourishes Aasti and Majjadhatu39,40 The colon is
considered as main seat of Vata, and Vata-alleviating
substances administered through the rectocolonic
route in Matrabasti are able to have their optimum
effect on the seat of Vata 41.
CONCLUSION
Although numerous modern treatments for various
forms of OA have been identified, they suffer from
various drawbacks, such as lack of efficacy, excessive
side effects and high cost42 The current pharmacologi-
cal management of osteoarthritis includes the admin-
istration of analgesics and NSAID’s , but their use
neither provides adequate pain relief nor deceleration
in disease process. In addition, NSAIDs are associated
with adverse effects 43, 44, 45. Due to which the use of
alternative therapies is on the rise. WHO recommends
to include traditional system of medicine in global
health care 46 Usually treatment of OA requires treat-
ment of the patient for their entire lifetime; therefore it
should be effective, friendly, safe and cheap. The goal
of OA treatment for medical profession is not only
control symptoms but also prevent disease progres-
sion, minimize disability, and improve quality of life.
Researchers claimed that Ayurveda treatment outcome
is better than or equal to conventional drug for im-
provement of pain and knee function 47. Hence it can
be concluded that Panchakarma (detoxification tech-
nique) has promising relief effect in osteoarthritis. 48
REFERENCES
1. Chu, C. R., Millis, M. B., & Olson, S. A. (2014)/ Oste-
oarthritis: From Palliation to Prevention: AOA Critical
Issues/ The Journal of bone and joint surgery American
/volume 96(15), e130/ PMID: 25100783; PMCID:
PMC4116563/ doi: 10.2106/JBJS.M.01209.
2. Golovach, I. Yu., Ye. D. Yehudina, & S.Kh. Ter-
Vartanian/ "Management of patients with knee osteoar-
Tanuja Mehta et al: Efficacy Of Panchakarma In Sandhivata W.S.R. To Knee Arthritis
doi:10.46607/iamj.3409012021 | IAMJ January 2021 | www.iamj.in
216
thritis in accordance with the recommendations of the
modern medical societies: focus on ESCEO 2019.
3. "TRAUMA [Online]/ volume 20 no.4 / Aug 2019 /
page no. 23-38/ Available at:
http://trauma.zaslavsky.com.ua/article/view/178743/18
0470 . Date accessed: 14 Aug. 2020. doi:
http://dx.doi.org/10.22141/1608-
1706.4.20.2019.178743.
4. Philippe Richebé, Xavier Capdevila, 3. David Zelman/
The Basics of Osteoarthritis/ WebMD Medical Reference/
June 02, 2020/ Arthritis Foundation, National Institute of
Arthritis and Musculoskeletal and Skin Diseases, Ameri-
can Academy of Orthopaedic Surgeons/ Available from-
https://www.webmd.com/osteoarthritis/guide/osteoarth
ritis-basics.
5. Cyril Rivat/ Persistent Postsurgical Pain: Pathophysiol-
ogy and Preventative Pharmacologic Considerations.
Anesthesiology/ ASAPublications/ sep.2018 volume
129(3) /590-607/ doi:
https://doi.org/10.1097/ALN.0000000000002238.
6. Akinpelu AO, Alonge TO, Adekanla BA, Odole AC/ A
community-based study/ Prevalence and pattern of
symptomatic knee osteoarthritis in Nigeria/ Internet
Journal of Allied Health Sciences and Practice/ Ju-
ly 2009/Volume 7 Number 3/page no.1.
7. Pal CP, Singh P, Chaturvedi S, Pruthi KK, Vij
A./Epidemiology of knee osteoarthritis in India and re-
lated factors/ Indian J Orthop/ 2016 Sep/ volume 50(5)
/ 518-522/ PMID: 27746495/ PMCID: PMC5017174/
doi: 10.4103/0019-5413.189608.
8. Davis MA, Ettinger WH, Neuhaus JM, Hauck
WW/Sex differences in osteoarthritis of the knee. The
role of obesity/ American journal of epidemiolo-
gy/1988 May/ volume 127(5)/ 1019-30/ PMID:
3358403/ doi:10.1093/oxfordjournals.aje.a114878.
9. Bennett, Coleman and Co. Ltd; c2013/ Osteoarthritis is
India's No.1ailment/ Times of India.com [article on In-
ternet] [Updated on 2007 Sep 6, Last accessed on 2011
Jul 31] /Available
from: http://www.articles.timesofindia.indiatimes.com/
2007-09-06/india/27968801_1_tns-arogya-
osteoarthritis-hiv-and-cancer.
10. Robinson WH, Lepus CM, Wang Q, Raghu H, Mao R,
Lindstrom TM, Sokolove J/ Low-grade inflammation
as a key mediator of the pathogenesis of osteoarthritis./
Nat Rev Rheumatol/ 2016 Oct/ volume12(10) / 580-
92./. 2016 Aug 19/ PMID: 27539668/ PMCID:
PMC5500215/ doi: 10.1038/nrrheum.2016.136.
11. Chahla J, Piuzzi NS, Mitchell JJ, Dean CS, Pascual-
Garrido C, LaPrade RF, Muschler GF/ Intra-Articular
Cellular Therapy for Osteoarthritis and Focal Cartilage
Defects of the Knee/ A Systematic Review of the Lit-
erature and Study Quality Analysis/ The Journal of
bone and joint surgery /American volume, 98(18)/
15111521/ 2016 Sep 21/PMID: 27655978.
12. Arden N, Nevitt MC. Osteoarthritis: Epidemiology.
Best Pract Res Clin Rheumatol. 2006 Feb;
20(1):325. DOI: https://doi.org/10.1016/j.berh.2005.09.
007. [PubMed] [Google Scholar].
13. Wluka AE, Lombard CB, Cicuttini FM/ Tackling obe-
sity in knee osteoarthritis/ Nat Rev Rheumatol/ . Epub
2012 Dec 18 / volume 9(4)/ page no.225-35/ doi:
10.1038/nrrheum.2012.224/ PMID: 23247649.
14. Duivenvoorden T, Brouwer RW, van Raaij TM, Ver-
hagen AP, Verhaar JA, Bierma-Zeinstra SM/ Braces
and orthoses for treating osteoarthritis of the knee/ The
Cochrane database of systematic reviews/ 2015 Mar
16/ volume 2015(3)/ PMID: 25773267/ PMCID:
PMC7173742/ doi:
10.1002/14651858.CD004020.pub3.
15. Riboh JC, Saltzman BM, Yanke AB, Fortier L, Cole
BJ/ Effect of leukocyte concentration on the efficacy of
platelet-rich plasma in the treatment of knee osteoar-
thritis/ Am J Sports Med/ 2016 Mar/ volume44(3)/
792
800/ DOI: https://doi.org/10.1177/0363546515580787.
16. Piuzzi NS, Slullitel PA, Bertona A, Oñativia JI, Alber-
go I, Zanotti G, Buttaro MA, Piccaluga F, Comba FM/
Hip arthroscopy in osteoarthritis: a systematic review
of the literature/Hip international: the journal of clini-
cal and experimental research on hip pathology and
therapy/ 2016 Jan-Feb/ volume 26(1)/ 8-14/ PMID:
26391259/ doi: 10.5301/hipint.5000299/.
17. Thorlund, J. B., Juhl, C. B., Roos, E. M., &
Lohmander, L. S/ (2015)/ Arthroscopic surgery for de-
generative knee: systematic review and meta-analysis
of benefits and harms /BMJ (Clinical research ed.)/
350/ PMID: 26080045; PMCID: PMC4469973 /h2747.
https://doi.org/10.1136/bmj.h2747.
18. Zuiderbaan, H. A., van der List, J. P., Kleeblad, L. J.,
Appelboom, P., Kort, N. P., Pearle, A. D., & Rade-
makers, M. V./ Sep-Oct 2016/ Modern Indications, Re-
sults, and Global Trends in the Use of Unicompart-
mental Knee Arthroplasty and High Tibial Osteotomy
in the Treatment of Isolated Medial Compartment Os-
teoarthritis/ American journal of orthopedics (Belle
Tanuja Mehta et al: Efficacy Of Panchakarma In Sandhivata W.S.R. To Knee Arthritis
doi:10.46607/iamj.3409012021 | IAMJ January 2021 | www.iamj.in
217
Mead, N.J.)/ 45(6), E355E361/ PMID: 27737301
[PubMed] [Google Scholar].
19. Wu CW, Morrell MR, Heinze E, et al. Validation of
American College of Rheumatology classification cri-
teria for knee osteoarthritis using arthroscopically de-
fined cartilage damage scores. Semin Arthritis
Rheum. 2005 Dec; 35(3) :197201. DOI:
https://doi.org/10.1016/j.semarthrit.2005.06.002.
[PubMed] [Google Scholar].
20. Altman R, Asch E, Bloch D, Bole G, Borenstein D,
Brandt K, Christy W, Cooke TD, Greenwald R,
Hochberg M, et al./ Development of criteria for the
classification and reporting of osteoarthritis. Classifica-
tion of osteoarthritis of the knee/ Diagnostic and Ther-
apeutic Criteria Committee of the American Rheuma-
tism Association. Arthritis Rheum /1986 Aug/ volume
29(8)/ 1039-49/ doi: 10.1002/art.1780290816./PMID:
3741515.
21. Vagbhatta/ Vagbhatta/ Ashtanga Hridayam/ Su-
trasthana/ Ayushkamiya Adhyaya/ 1/7./English transla-
tion by KRS Murthy/Vol. 1./ Varanasi/ Chaukhambha
Sanskrit Samsthan/ 2009/ p. 6.
22. Tripathi Brahmanand Editor Charak Samhita With
Hindi Translation, Chaukhamba subhartiprakash-
an/Varanasi, 2008; 28:618.
23. Kaviraj ambikadutta Shastri, Editor, Sushrutha Sam-
hita, Nidanasthana, Chapter 1, Shloka 28, 11th Edition,
Chaukhamba Sanskrit Samsthan; Varanasi: 1997; P.
230.
24. Mahamahopadyaya Sri Vijayarakshita, Srikanthadut-
tadyam, Madhavanidanam, 22ndchapter, Vatavyadhini-
dana, Chaukhambasurbharatiprakashan; Varanasi:
2007; P. 520.
25. Daksha Rathod et.al / Effect of Yoga Basti in Sandhi-
vata w.s.r. to Osteoarthritis of Knee Joint /Published
online in http://ijam.co.in.
26. Vaidya Yadunandana, Astangahrdaya Of Vagabhata
Edited With ‘Vidyotini’ Hindi Commentary By Ka-
viraja Gupta, Chaukhambha Prakashan, Varanasi, Re-
print 2007, 13th Chapter 1st, 2nd, 3rd Slokas, Page No
96, 97.
27. Vaidya Yadavaji Trikamji Acharya, Susrutha Samhita
With Nibandhasangraha Commentary Of Sri Dalhana
Acharya, Chaukhambha Surbharati Prakashan, Varana-
si, Reprint2012, Chikitsa Sthana, 4th Chapter, 8th Slo-
ka, Page No-820.
28. Dr Ashish Mishra , Dr Pankaj Nigam// Role of Pan-
chakarma in Various Disorders Associated with Pain
W.S.R. to Sciatica, Spondylitis and Osteoarthritis / Re-
view Article/ Journal of Drug Delivery and Therapeu-
tics/15.07.2018/ Available online on at http://jddtonline
29. Sharma MR, Mehta CS, Shukla DJ, Patel KB, Patel
MV, Gupta SN/ Multimodal Ayurvedic management
for Sandhigatavata (Osteoarthritis of knee joints)/ AYU
[serial online] /2013 [cited 2020 Aug 14]/ volume34/
page no.49-55/ Available
from: http://www.ayujournal.org/text.asp?2013/34/1/49
/115447.
30. Brunton LL editor/ 12th ed./ New Delhi/ McGraw-Hill
Professional/ 2011. Goodman and Gilman's The Phar-
macological Basis of Therapeutics/ p. 22.
31. Rajorio K, et al./ “Clinical study on Laksha Guggulu,
Snehana, Swedana & Traction in Osteoarthritis (Knee
joint).”/ Ayu. /2010. Jan-Mar/ volume 31(1)/ page no.
8087.
32. Agnivesha, Charaka, Dridhabala. Charaka Samhita
Vol. 1, Sutra Sthana Svedadhyaya, 14/24, Shastri K,
editor. Varanasi: Chaukhambha Sanskrit Samsthan;
2004. p. 286.
33. Ibidem. Charaka Samhita, Vol. 1, Sutra Sthana,
Langhana-Brihaniya Adhyaya, 22/11. :424. [Google
Scholar].
34. Sushruta. In: Sushruta Samhita-Vol. 2, Chikitsa Sthana,
Svedavacharaniyachikitsa Adhyaya, 32/3. Sharma AR,
editor. Varanasi: Chaukhambha Sanskrit Samsthan;
2004. p. 416. [Google Scholar].
35. Ibidem. Shusruta Samhita, Vol. 2, Chikitsa Sthana,
Vatavyadhichikitsitam, 4/8. :205. [Google Scholar].
36. Agnivesha, Charaka, Dridhabala . In: Charaka Samhita
Vol. 1, Sutra Sthana Yajjapurushiya Adhyaya,
25/40. Shastri K, editor. Varanasi: Chaukhambha San-
skrit Samsthan; 2004. p. 468. [Google Scholar].
37. Grampurohit, P. L., Rao, N., & Harti, S. S./ 2014/ Ef-
fect of anuvasana basti with ksheerabala taila in
sandhigata vata (osteoarthritis)/ Ayu/ volume 35(2)/
pageno.148151/ available from
https://doi.org/10.4103/0974-8520.146225.
38. Satish Kumar Singh N.P.Rai, V.K.Shrivastav/ Role Of
An Ayurvedic Compound Drug And Brimhana Basti In
The Management Of Sandhivata Viz Osteoarthritis/ Int.
J. Res. Ayurveda Pharma/ 2015/ volume(4)/429-434/
Http//Dx.Doi.Org/10.7897/2277-4343.06482.
39. Acharya Y T, Charak Samhita of Agnivesh, Rashtriya
Sanskrit Sansthan New Delhi, Chaukambha prakashan
Varanasi 2006, P 72.
40. Acharaya Vaidya Jadavjitrikamjieditor Chikitsasthan,
Agnivesh, Charak Samhita With Commen-
Tanuja Mehta et al: Efficacy Of Panchakarma In Sandhivata W.S.R. To Knee Arthritis
doi:10.46607/iamj.3409012021 | IAMJ January 2021 | www.iamj.in
218
tary,Chakarpanidattachaukhambha Sanskrit Sansthan-
press, Varanasi.2008: 28: 618.
41. Agnivesha, Charaka, Dridhabala . Charaka Samhita,
Sutra Sthana, Snehadhyaya 13/98. In: Tripathi B,
Deshpande PJ, editors. Reprint ed. Varanasi:
Chaukambha Sanskrit Pratishtan; 2003. p.
284. [Google Scholar].
42. Agnivesha, Charaka, Dridhabala. Charaka Samhita
Vol. 2, Siddhi Sthana Snehavyapadasiddhi Adhyaya,
4/53. In: Shastri K, editor. Varanasi: Chaukhambha
Sanskrit Samsthan; 2004. p. 1013. [Google Scholar].
43. Ashok Kumar Panda / 2015/ Ayurveda Treatment Out-
comes for Osteoarthritis/ J Homeop Ayurv Med
/4:e115/ doi: 10.4172/2167-1206.1000e115.
44. Bennett, Coleman and Co. Ltd; c2013/ Osteoarthritis is
India's No.1 ailment/ Times of India.com [article on In-
ternet] [Updated on 2007 Sep 6, Last accessed on 2011
Jul 31] /Available
from: http://www.articles.timesofindia.indiatimes.com/
2007-09-06/india/27968801_1_tns-arogya-
osteoarthritis-hiv-and-cancer.
45. 44.Eustice C/ Guide to Osteoarthritis, Part 4 of 5-
Osteoarthritis Medications and Other Drug Options/
About.com [article on Internet] /c2013/ [Updated on
2007 Apr 7, Last accessed on 2011 Aug 5] /Available
from: http://www.arthritis.about.com/od/oa/a/Osteo_art
hritis_4.htm.
46. NSAID use associated with future stroke in healthy
population/ [article on Internet]/ Sweden/ The heart.org
by WebMD/ c1999-2012/ [Updated on 2010 Sept8,
Last accessed on 2011 Aug 26] /Available from:
http://www.theheart.org/article/1119849.
47. World Health Organization/ Benchmarks for Training
in Traditional/Complementary and Alternative Medi-
cine: Benchmarks for Training in Traditional Chinese
Medicine/ Vol. 30/ Geneva/2010.
48. Sunil Jawla, Gupta AK, Rachit Singla, Varun Gupta/
(2009)/ General awareness and relative popularity of
allopathic, ayurvedic and homeopathic systems/Journal
of Chemical and Pharmaceutical Research
/volime1/pageno. 105-112/available from-:
http://jocpr.com/.../JOCPR-10.pdf.
49. Chopra A, Saluja M, Tillu G, Sarmukkaddam S, Venu-
gopalan A, Narsimulu G, Handa R, Sumantran V, Raut
A, Bichile L, Joshi K, Patwardhan B/ Ayurvedic medi-
cine offers a good alternative to glucosamine and
celecoxib in the treatment of symptomatic knee osteo-
arthritis/ a randomized, double-blind, controlled equiv-
alence drug trial/ Rheumatology (Oxford, Eng-
land/2013 Aug/ volume 52(8)/ 1408-17/ PMID:
23365148./ doi: 10.1093/rheumatology/kes414.
Source of Support: Nil
Conflict of Interest: None Declared
How to cite this URL: Tanuja Mehta et al: Efficacy Of
Panchakarma In Sandhivata W.S.R. To Knee Arthritis.
International Ayurvedic Medical Journal {online} 2021 {cited
January, 2021} Available from:
http://www.iamj.in/posts/images/upload/212_218.pdf
Article
Full-text available
Остеоартрит (ОА) является наиболее распространенной формой артрита, характеризующейся разрушением суставного хряща, воспалением синовиальной оболочки и ремоделированием субхондральной кости. Коленный сустав является самой распространенной локализацией ОА, и ОА коленного сустава наиболее часто поражает людей старше 50 лет. Кроме того, ОА является основной причиной боли у пожилых людей, хроническая боль в бедре и колене приводит к инвалидности и повышенному риску смертности от всех причин. Целью лечения ОА является уменьшение симптомов и замедление прогрессирования заболевания, что, в свою очередь, может снизить влияние ОА на качество жизни пациента. В настоящее время различные академические и профессиональные общества разработали руководящие принципы для стандартизации ведения пациентов с ОА и рекомендации доступных вариантов лечения. Физическая активность поддерживается всеми современными медицинскими обществами, в то время как в отношении назначения других вмешательств и лекарственных средств различные сообщества дают противоречивые доказательства. Последние обновленные рекомендации 2019 года по лечению пациентов с ОА коленных суставов, представленные Европейским обществом по клиническим и экономическим аспектам остеопороза, остеоартрита и заболеваний опорно-двигательного аппарата (ESCEO), включают 15 рекомендаций по лечению и обновленный ступенчатый алгоритм для менеджмента пациентов с ОА коленного сустава, что обеспечивает практическое руководство для врача в свете последних данных об эффективности и безопасности препаратов согласно данным недавних исследований. Алгоритм ESCEO подчеркивает сохраняющуюся важность нефармакологических вмешательств на всем протяжении лечения ОА. В статье рассматриваются преимущества и ограничения различных нефармакологических, фармакологических и хирургических методов лечения ОА с особым акцентом на их безопасность.
Article
Full-text available
Purpose: Osteoarthritis (OA) is a leading cause of disability, affecting 60-70% of people aged ≥60 years. Community-based prevalence estimates of OA in Nigeria are not readily available for referencing. This study investigated the prevalence and pattern of knee OA in Igbo-Ora, a rural community in Southwestern Nigeria. Methods: A total of 1044 adults (487 males, 557 females) aged ≥ 40 years in Igbo-Ora were recruited into this door-to-door survey through multi-stage cluster sampling. Knee OA was diagnosed using the American College of Rheumatology (ACR) clinical criteria. Knee OA severity was assessed using the Lequesne Algofunctional Index and interference with role performance was rated by participants who met the ACR criteria. Plain radiographs of a multiphase sample of 15 participants with Knee OA were taken. Data was analysed using percentages and Chi square. Results: Two hundred and five (119 females, 86 males) out of the 1044 participants fulfilled the ACR criteria, giving a point prevalence of symptomatic knee OA of 19.6%. The prevalence of knee OA was 21.4% among the females and 17.5% among the males, giving a female bias in the ratio of 1.2:1. Prevalence increased and was significantly associated (P<0.001) with age. Most participants (98.5%) had moderate-extremely severe disease and knee OA interfered with role performance in 90.2% of participants. All radiographs showed signs consistent with OA. Conclusion: One out of every five adults aged ≥40 years in this Nigerian rural community has symptomatic knee OA, with a female preponderance in the ratio of 1.2:1.
Article
Full-text available
In this review, we evaluate the modern indications, subjective outcome scores, and survivorship results of unicompartmental knee arthroplasty (UKA) and high tibial osteotomy (HTO) in the treatment of isolated medial compartment degeneration of the knee. In addition, in a thorough review of the literature, we evaluate global trends in the use of both methods. In our evaluation of articles, we note that inclusion criteria are relatively broader for UKA than for HTO, where age and body mass index should be considered before HTO surgery in order to optimize clinical outcome and survivorship results. Exact thresholds for UKA inclusion have been studied, but there is no clear definition. Both methods have good to excellent subjective outcome scores. Expected 10-year survivorship results are in favor of UKA (90%) over HTO (75%). However, controlled data directly comparing both methods are lacking. The broad range of UKA inclusion criteria and good to excellent subjective and survivorship results have led to an increase in UKA use among Western practices, whereas use of HTO in patients with isolated single-compartment osteoarthritis has been decreasing.
Article
Full-text available
Background: Intra-articular cellular therapy injections constitute an appealing strategy that may modify the intra-articular milieu or regenerate cartilage in the settings of osteoarthritis and focal cartilage defects. However, little consensus exists regarding the indications for cellular therapies, optimal cell sources, methods of preparation and delivery, or means by which outcomes should be reported. Methods: We present a systematic review of the current literature regarding the safety and efficacy of cellular therapy delivered by intra-articular injection in the knee that provided a Level of Evidence of III or higher. A total of 420 papers were screened. Methodological quality was assessed using a modified Coleman methodology score. Results: Only 6 studies (4 Level II and 2 Level III) met the criteria to be included in this review; 3 studies were on treatment of osteoarthritis and 3 were on treatment of focal cartilage defects. These included 4 randomized controlled studies without blinding, 1 prospective cohort study, and 1 retrospective therapeutic case-control study. The studies varied widely with respect to cell sources, cell characterization, adjuvant therapies, and assessment of outcomes. Outcome was reported in a total of 300 knees (124 in the osteoarthritis studies and 176 in the cartilage defect studies). Mean follow-up was 21.0 months (range, 12 to 36 months). All studies reported improved outcomes with intra-articular cellular therapy and no major adverse events. The mean modified Coleman methodology score was 59.1 ± 16 (range, 32 to 82). Conclusions: The studies of intra-articular cellular therapy injections for osteoarthritis and focal cartilage defects in the human knee suggested positive results with respect to clinical improvement and safety. However, the improvement was modest and a placebo effect cannot be disregarded. The overall quality of the literature was poor, and the methodological quality was fair, even among Level-II and III studies. Effective clinical assessment and optimization of injection therapies will demand greater attention to study methodology, including blinding; standardized quantitative methods for cell harvesting, processing, characterization, and delivery; and standardized reporting of clinical and structural outcomes. Level of evidence: Therapeutic Level III. See Instructions for Authors for a complete description of levels of evidence.
Article
Full-text available
Background: Among the chronic rheumatic diseases, hip and knee osteoarthritis (OA) is the most prevalent and is a leading cause of pain and disability in most countries worldwide. Its prevalence increases with age and generally affects women more frequently than men. OA is strongly associated with aging and heavy physical occupational activity, a required livelihood for many people living in rural communities in developing countries. Determining region-specific OA prevalence and risk factor profiles will provide important information for planning future cost effective preventive strategies and health care services. Materials and Methods: The study was a community based cross sectional study to find out the prevalence of primary knee OA in India which has a population of 1.252 billion. The study was done across five sites in India. Each site was further divided into big city, small city, town, and village. The total sample size was 5000 subjects. Tools consisted of a structured questionnaire and plain skiagrams for confirmation of OA. Diagnosis was done using Kellgren and Lawrence scale for osteoarthritis. Results: Overall prevalence of knee OA was found to be 28.7%. The associated factors were found to be female gender (prevalence of 31.6%) (P = 0.007), obesity (P = 0.04), age (P = 0.001) and sedentary work (P = 0.001). Conclusions: There is scarcity of studies done in India which has varied socio geographical background and communities. We conducted this study for analyzing the current prevalence of OA in different locations. This study has evidenced a large percentage of population as borderline OA; therefore, it depends mainly on the prevention of modifiable risk factors to preserve at ease movement in elderly population through awareness programs.
Article
Sandhivata (Osteoarthritis) is one of the Vataja vyadhi (disease due to Vata Dosha) and most common degenerative disease seen in old age people. The Ayurvedic approach to the management of Sandhivata is to provide the complete cure. Objective of the present study was to evaluate the effect of Erandamooladi Niruha Basti and Dashamooladi Anuvasana Basti as Yoga Basti in Sandhivata w.s.r to osteoarthritis of knee joint. Method: 30 patients fulfilling the inclusion criteria of Sandhivata were randomly selected in a single group and treated with Yoga Basti [Dashmooladi Anuvasan Basti and Erandmooladi Niruha Basti] daily in the morning for a period of 8 days. Clinical signs and symptoms were given suitable scores according to their severity and assessed based on pre and post data gathered through pre-designed research clinical proforma. The results having ‘P’ value less than 0.0001 was considered to be statistically significant in this study. Result: All the patients in the group showed highly significant improvement in all the symptoms. Pain relieved 80.77%, stiffness  relieved 84.39%, fatigue relieved 100%, restricted movement  reduced by 100 % and deformity reduced by 74.15%. Conclusion: Yoga Basti is found effective in the management of Sandhivata with reference to osteoarthritis of knee joint.All the patients responded to the given treatment without any adverse effects and complications. Mild to marked relief was found in all the symptoms of Sandhivata .Â
Article
Ayurveda is a system of medicines practicing in India anciently. The concepts and belief of ayurveda based on logical reasoning and experimental observations. Ayurveda not only mentioned approaches of disease prevention but also described preventive measure to maintain good health status. The therapeutic measures of ayurveda not only involves use of medicine but also utilizes other approaches such as; Panchakarma. Panchakarma is a Shodhana Chikitsa and approved as vital therapy for the management of various disorders. Panchakarma offer various therapeutic benefits such as; detoxification, improved circulation, relief spasm and pain. The efficacy of Panchakarma also well proven in pain related diseases. This article presented role of Panchakarma in pain W.S.R. to Sciatica, Spondylitis and Osteoarthritis. Keywords: Ayurveda, Panchakarma, Shodhana Chikitsa, Shoola roga, Sciatica.
Article
The development of chronic pain is considered a major complication after surgery. Basic science research in animal models helps us understand the transition from acute to chronic pain by identifying the numerous molecular and cellular changes that occur in the peripheral and central nervous systems. It is now well recognized that inflammation and nerve injury lead to long-term synaptic plasticity that amplifies and also maintains pain signaling, a phenomenon referred to as pain sensitization. In the context of surgery in humans, pain sensitization is both responsible for an increase in postoperative pain via the expression of wound hyperalgesia and considered a critical factor for the development of persistent postsurgical pain. Using specific drugs that block the processes of pain sensitization reduces postoperative pain and prevents the development of persistent postoperative pain. This narrative review of the literature describes clinical investigations evaluating different preventative pharmacologic strategies that are routinely used by anesthesiologists in their daily clinical practices for preventing persistent postoperative pain. Nevertheless, further efforts are needed in both basic and clinical science research to identify preclinical models and novel therapeutics targets. There remains a need for more patient numbers in clinical research, for more reliable data, and for the development of the safest and the most effective strategies to limit the incidence of persistent postoperative pain.
Article
Osteoarthritis (OA) has long been viewed as a degenerative disease of cartilage, but accumulating evidence indicates that inflammation has a critical role in its pathogenesis. Furthermore, we now appreciate that OA pathogenesis involves not only breakdown of cartilage, but also remodelling of the underlying bone, formation of ectopic bone, hypertrophy of the joint capsule, and inflammation of the synovial lining. That is, OA is a disorder of the joint as a whole, with inflammation driving many pathologic changes. The inflammation in OA is distinct from that in rheumatoid arthritis and other autoimmune diseases: it is chronic, comparatively low-grade, and mediated primarily by the innate immune system. Current treatments for OA only control the symptoms, and none has been FDA-approved for the prevention or slowing of disease progression. However, increasing insight into the inflammatory underpinnings of OA holds promise for the development of new, disease-modifying therapies. Indeed, several anti-inflammatory therapies have shown promise in animal models of OA. Further work is needed to identify effective inhibitors of the low-grade inflammation in OA, and to determine whether therapies that target this inflammation can prevent or slow the development and progression of the disease.